updated January 24, 2022
If you receive a Pfizer-BioNTech or Moderna COVID-19 vaccine, you will need 2 shots to get the most protection. If you receive your second shot of COVID-19 vaccine later than recommended, you do NOT have to restart the vaccine series.
- If you received a Pfizer-BioNTech or Moderna COVID-19 vaccine, you should get the same product for your second shot. You should get your second shot even if you have side effects after the first shot, unless a vaccination provider or your doctor tells you not to get it.
- The timing between your first and second shots depends on which vaccine you received. If you received the Pfizer-BioNTech COVID-19 Vaccine, you should get your second shot 3 weeks (or 21 days) after your first. If you received the Moderna COVID-19 Vaccine, you should get your second shot 4 weeks (or 28 days) after your first.
- You should get your second shot as close to the recommended 3-week or 4-week interval as possible. However, your second dose may be given up to 6 weeks (42 days) after the first dose, if necessary. You should not get the second dose early.
- UPATED February 24, 2022: CDC updated its COVID-19 vaccination guidance with additional information to help vaccine providers determine the optimal interval between the first and second dose of an mRNA vaccine series, based on the individual patient. These additional considerations followed a thorough evaluation of the latest safety and effectiveness data, and evidence from hundreds of millions of COVID-19 vaccines that have already been safely administered in the United States, and the billions of vaccines administered in other countries.New data indicate that some people ages 12 through 64 years—and especially males ages 12 through 39 years—would benefit from getting their second mRNA COVID-19 vaccine dose 8 weeks after receiving their first dose. Extending the time interval between primary mRNA COVID-19 vaccine doses from the FDA-approved or authorized 3 weeks (Pfizer-BioNTech) or 4 weeks (Moderna) to 8 weeks may help increase how long protection lasts against COVID-19. It may also help lower the (small) risk of myocarditis (inflammation of the heart muscle) and pericarditis (swelling of tissue around the heart), which has been associated—mostly among adolescent and young adult males—with mRNA COVID-19 vaccination. Regardless of the interval between the first and second dose, mRNA vaccines are highly effective at reducing the risk of hospitalization and serious complications from COVID-19 infection. And people who have already received their primary mRNA series at the 3-week or 4-week interval remain well-protected—especially if they have received a booster dose.
- Planning for your second shot is important. If you need help scheduling your vaccination appointment for your second shot, contact the location that set up your first appointment. If you are having trouble or have questions about using a vaccination management or scheduling system, reach out to the organization that enrolled you in the system. This may be your state or local health department, employer, or vaccination provider. Scheduling an appointment for your second shot at the time you get your first shot is recommended, but not required.
- If you need to get your second shot in a location that is different from where you received your first shot (for example, if you moved to a different state or attend school in a different state), there are several ways you can find a vaccine provider for your second dose.
For more information, visit https://www.cdc.gov/…/2019-ncov/vaccines/second-shot.html
Search for your COVID-19 vaccine record at the Virginia Department of Health‘s Vaccination Record Request Portal. Once you have accessed your record, it can be saved, printed, or downloaded as a PDF.
Your vaccination record will only show COVID-19 immunizations.
If you received vaccines out of state or if a federal agency administered your vaccines, they will not show up in this self-serve portal.
This portal is not a “vaccine passport” but serves as a way to prove you were vaccinated for COVID-19.